A Monex subsidiary has rebuffed an Indian drugmaker's £19.4 million ($24 million) lawsuit for canceling currency exchange contracts, saying it was entitled to do so after the pharma firm's offices were raided by the country's authorities.
The study showed that patients receiving the 25-hydroxy metabolite had, in comparison to those receiving a placebo, demonstrably more favourable development of their immunological defence against COVID-19.